Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled study of HSK16149 in Chinese adults with moderate to severe central neuropathic pain
CTR20241405Phase 3Completed
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.
- Start
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of crisugabalin besilate in central neuropathic pain (CNP), sponsored by Haisco Pharmaceutical Group Co., Ltd.. Started May 2024; status: completed.
02
Drugs
crisugabalin besilate
03
Conditions
central neuropathic pain (CNP)
Beyond the preview
Go deeper on CTR20241405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241405.